<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2017-11-07">November 7, 2017</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Yue</forename><surname>Dong</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Ministry of Education</orgName>
								<orgName type="department" key="dep2">Zhejiang Provincial Key Laboratory of Medical Genetics</orgName>
								<orgName type="laboratory">Key Laboratory of Laboratory Medicine</orgName>
								<orgName type="institution">Wenzhou Medical University</orgName>
								<address>
									<settlement>Wenzhou</settlement>
									<country key="CN">P.R. China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sebastian</forename><surname>Ochsenreither</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Hematology, Oncology and Tumorimmunology</orgName>
								<orgName type="institution" key="instit1">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Freie Universita ¨t Berlin</orgName>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution" key="instit1">Humboldt-Universita ¨t zu Berlin</orgName>
								<orgName type="institution" key="instit2">Berlin Institute of Health</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Chengxuan</forename><surname>Cai</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Ministry of Education</orgName>
								<orgName type="department" key="dep2">Zhejiang Provincial Key Laboratory of Medical Genetics</orgName>
								<orgName type="laboratory">Key Laboratory of Laboratory Medicine</orgName>
								<orgName type="institution">Wenzhou Medical University</orgName>
								<address>
									<settlement>Wenzhou</settlement>
									<country key="CN">P.R. China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Andreas</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Clinic for Gynecology</orgName>
								<orgName type="institution" key="instit1">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Freie Universita ¨t Berlin</orgName>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution" key="instit1">Humboldt-Universita ¨t zu Berlin</orgName>
								<orgName type="institution" key="instit2">Berlin Institute of Health</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Andreas</forename><forename type="middle">E</forename><surname>Albers</surname></persName>
							<email>andreas.albers@charite.de</email>
							<affiliation key="aff5">
								<orgName type="department">Department of Otorhinolaryngology, Head and Neck Surgery</orgName>
								<orgName type="institution" key="instit1">Charite ´-Universita ¨tsmedizin Berlin</orgName>
								<orgName type="institution" key="instit2">Freie Universita ¨t Berlin</orgName>
								<orgName type="institution" key="instit3">Humboldt-Universita ¨t zu Berlin</orgName>
								<orgName type="institution" key="instit4">Berlin Institute of Health</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Xu</forename><surname>Qian</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Ministry of Education</orgName>
								<orgName type="department" key="dep2">Zhejiang Provincial Key Laboratory of Medical Genetics</orgName>
								<orgName type="laboratory">Key Laboratory of Laboratory Medicine</orgName>
								<orgName type="institution">Wenzhou Medical University</orgName>
								<address>
									<settlement>Wenzhou</settlement>
									<country key="CN">P.R. China</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">Augusta University</orgName>
								<address>
									<country key="US">UNITED STATES</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Aldehyde dehydrogenase 1 isoenzyme expression as a marker of cancer stem cells correlates to histopathological features in head and neck cancer: A meta-analysis</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2017-11-07">November 7, 2017</date>
						</imprint>
					</monogr>
					<idno type="MD5">6A7E9BA4A596002BE6B67E04B619605C</idno>
					<idno type="DOI">10.1371/journal.pone.0187615</idno>
					<note type="submission">Received: April 3, 2017 Accepted: October 23, 2017</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:26+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>There is a lack of predictive biomarkers that can identify patients with head and neck squamous cell carcinoma (HNSCC) who will experience treatment failure and develop drug resistance, recurrence, and metastases.</s><s>Cancer stem-like cells (CSC) were identified as a subset of cells within the tumor in a variety of solid tumors including HNSCC.</s><s>CSC are considered the tumor-initiating population responsible for recurrence or metastasis and are associated with therapy resistance.</s><s>This meta-analysis including fourteen studies with altogether 1258 patients updates and summarizes all relevant data on the impact of ALDH1 + CSC on the prognosis of HNSCC and its association with clinicopathological parameters.</s><s>ALDH1 expression is highly correlated with tumor differentiation (G3 vs. G1+G2; odds ratio = 2.85.</s><s>95% CI: 1.72-4.73,</s><s>P&lt;0.0001) and decreased overall survival (relative risk = 1.77.</s><s>95% CI: 1.41-2.22,</s><s>P&lt;0.0001) if one out of seven studies was excluded because of heterogeneity.</s><s>These findings provide insights into the understanding of more aggressive tumor phenotypes and also suggest that the prognostic value provided by HNSCC-subtyping by CSC frequency warrant further clinical investigation.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>Recent discoveries in cancer research continue to support the theory that cancer stem cells (CSC) initiate metastasis formation and tumor recurrence after initial therapy <ref type="bibr" target="#b0">[1,</ref><ref type="bibr" target="#b1">2]</ref>.</s><s>Such a cancer initiating cell population has not only been described for head and neck squamous cell carcinoma (HNSCC) but also proved being relevant for clinical outcome of patients with such a disease as observed by our group and others <ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr" target="#b5">[5]</ref>.</s><s>HNSCC is regarded one of the most prevalent malignant diseases worldwide.</s><s>Multimodal treatment strategies have substantially improved survival in patients with curative potential <ref type="bibr" target="#b6">[6]</ref><ref type="bibr" target="#b7">[7]</ref><ref type="bibr" target="#b8">[8]</ref><ref type="bibr" target="#b9">[9]</ref>.</s><s>However, treatment decision in clinical routine especially for locally advanced (LA) HNSCC remains a challenge and is based on conventional factors such as tumor stage, comorbidities and a patient's responses to ongoing treatments <ref type="bibr" target="#b10">[10]</ref>.</s><s>Among patients who had LA diseases and even with similar histopathological characteristics, diversity in responses to the same treatment regimen resulting also in differences in prognosis suggests so far unknown determining parameters <ref type="bibr" target="#b11">[11]</ref>.</s><s>Thus, additional stratification factors could augment the TNM staging system to improve prediction of long-term survival.</s><s>That is, biomarker stratified treatment strategies could become a reality.</s><s>Although HNSCC prognosis, and specifically in oropharyngeal cancer (OPSCC), has clearly been influenced by detection of human papilloma virus (HPV) infection <ref type="bibr" target="#b12">[12]</ref>, additional biomarkers are needed for HPV-negative tumors.</s><s>Furthermore, in case CSC have a predictive or prognostic role for patients with HNSCC as suggested by preclinical studies, the targeting of the CSC cell population in combination with conventional therapies aiming at a reduction or eradication of the bulk tumor would be a reasonable approach to improve therapeutic efficacy by prevention of local recurrence or metastasis formation.</s></p><p><s>CSC can be defined by their biological features like unlimited proliferative capacity, and enhanced resistance to conventional treatment modalities like chemotherapy or radiation, by phenotypical markers like receptor expression, or by indirect detection of specific transmembrane transporter molecules.</s><s>Among these CSC markers, the aldehyde dehydrogenase 1 (ALDH1) isoenzymes, which can be detected by their enzymatic function as well as by immunohistochemistry, are well studied in HNSCC.</s><s>ALDH1 is associated with a stem cell-like phenotype, which is among other mechanisms a direct consequence of its obvious activity for oxidation of retinal to retinoic acid leading to cell differentiation <ref type="bibr" target="#b13">[13]</ref>.</s><s>Furthermore, ALDH1 expression enhances resistance to several anticancer drugs by its catalytic activity <ref type="bibr" target="#b14">[14]</ref>.</s><s>In cell lines, ALDH1-positivity is associated with tumorigenesis and resistance to chemo-radiation <ref type="bibr" target="#b3">[4,</ref><ref type="bibr" target="#b15">15]</ref>.</s><s>ALDH1A1 positive CSCs are found both in primary tumors originating from the oral cavity, oropharynx, hypopharynx and larynx <ref type="bibr" target="#b5">[5]</ref> and in lymph node metastases <ref type="bibr" target="#b16">[16,</ref><ref type="bibr" target="#b17">17]</ref>.</s><s>Clinical studies have shown the prognostic value of ALDH1A1 in patients with LA HNSCC as well as in patients with nodal and visceral metastatic disease <ref type="bibr" target="#b5">[5,</ref><ref type="bibr" target="#b17">17]</ref>.</s></p><p><s>Because of the persistence of CSC during therapy, which contributes to tumor relapse and its capacity for recapitulation of the heterogeneous features of a cancer, eradication of CSC is viewed as an important challenge for a successful cancer therapy.</s><s>In a recent ex vivo study, NCT-501, a theophylline-based inhibitor of ALDH1A1, was able to overcome secondary resistance to several chemotherapeutic agents.</s><s>The combination with cisplatin treatment was found to significantly decrease the proliferation of primary HNSCC cells compared to treatment with the individual agents <ref type="bibr" target="#b18">[18]</ref>.</s><s>Moreover, ALDH1A1 has been proven to be immunogenic and a target for cytotoxic T-cells.</s><s>It has been shown that T-cell lines specific for MHC class I-restricted epitopes of ALDH1A1 can eliminate ALDH1A1 positive cancer cells in HNSCC <ref type="bibr" target="#b19">[19,</ref><ref type="bibr" target="#b20">20]</ref>.</s><s>These observations imply a clinical usefulness of ALDH1A1 not only as a predictive biomarker but as potential target in HNSCC.</s></p><p><s>In order to assess clinical and biological characteristics such as histological appearance, lymph node metastasis and patient's survival in relation to ALDH1 expression in HNSCC, we conducted a systematic review of the literature and meta-analysis.</s><s>Strategies targeting ALDH1 positive CSC are also discussed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Literature search strategy and selection criteria</head><p><s>Electronic literature databases PubMed, EMBASE, the Cochrane Library, and WangFang databases for studies published before December 31 st , 2016 were searched using the following key words: "ALDH1" or "aldehyde dehydrogenase 1" and "head and neck squamous cell" or "oral" or "laryngeal" or "pharyngeal" or "tongue" or "oropharyngeal" and "cancer" or "carcinoma" or "neoplasms".</s><s>Titles and abstracts were scanned to identify the candidate publications.</s><s>Systematic reviews, letters, and case studies were excluded.</s><s>Manuscripts from the reference lists of original or review articles were also screened for additional publications.</s><s>In a second step, fulltext articles were assessed to check for eligibility.</s><s>To be included in the current study, original articles were required to meet the following criteria: (1) patients with HNSCC; (2) correlations between ALDH1 overexpression and histopathological parameters, overall survival (OS) or disease-free survival (DFS) of HNSCC patients were analyzed.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Data extraction</head><p><s>Pivotal data were extracted from all eligible publications independently by two of the authors (DY and QX).</s><s>For this, data tables were composed to extract all relevant data from texts, tables and figures including patient characteristics, tumor stages and additional clinical features together with clinical endpoints like OS and DFS.</s><s>Additionally, for each article, the authors, the year of publication, and the number of patients were extracted.</s><s>To digitalize and extract survival data from Kaplan-Meier plot curves, the software GraphClick (Version 3.0.2,</s><s>Arizona Software 2010, http://www.arizona-software.ch/graphclick) was used.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Study quality</head><p><s>The Newcastle-Ottawa Scale (NOS), a risk of bias assessment tool for observational studies, was used to evaluate the methodological quality of included studies <ref type="bibr" target="#b21">[21,</ref><ref type="bibr" target="#b22">22]</ref>.</s><s>The quality assessment values ranged from 0 to 9 points.</s><s>There are three categories including selection (4 points), comparability (2 points), and exposure (3 points) (S2 Table <ref type="table">)</ref>.</s><s>The result was an overall risk of bias rating of each study and score !5 is considered high quality <ref type="bibr" target="#b22">[22]</ref>.</s><s>Two independent reviewers evaluated the risk of bias for each study.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>All statistical analyses were performed using the methods described in the Cochrane Handbook for Systematic Review of Interventions <ref type="bibr" target="#b23">[23]</ref>, using the Reviewer Manager Software, version 5.3 (Cochrane Library, Oxford, UK) and STATA 12.1 (StataCorp LP, Texas, USA).</s><s>The impact of ALDH1 overexpression on dichotomous data was expressed as the odds ratio (OR) and risk ratio (RR) with 95% Confidence Intervals (CI).</s><s>OR was used to assess the association between ALDH1 overexpression and clinicopathological parameters such as clinical stage including lymph node status and tumor histology.</s><s>RR was used to assess the association between ALDH1 overexpression and outcome (OS and DFS) <ref type="bibr" target="#b24">[24]</ref>.</s></p><p><s>We assessed the statistical heterogeneity by observing I-squared (I 2 ) and Q test <ref type="bibr" target="#b25">[25,</ref><ref type="bibr" target="#b26">26]</ref>.</s><s>If a significant heterogeneity existed (I 2 &gt;50% or P&lt;0.05), a random effect model was used to calculate OR and RR.</s><s>Otherwise a fixed effect model was used <ref type="bibr" target="#b26">[26]</ref>.</s><s>In order to explore the possible sources of heterogeneity, subgroup analyses and sensitivity analyses were conducted.</s><s>In addition, Egger's test was used to evaluate the publication bias <ref type="bibr" target="#b27">[27]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Description of the included studies</head><p><s>155 studies were retrieved from the databases and 14 studies <ref type="bibr" target="#b5">[5,</ref><ref type="bibr" target="#b16">16,</ref><ref type="bibr" target="#b17">17,</ref><ref type="bibr" target="#b28">[28]</ref><ref type="bibr" target="#b29">[29]</ref><ref type="bibr" target="#b30">[30]</ref><ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref><ref type="bibr" target="#b34">[34]</ref><ref type="bibr" target="#b35">[35]</ref><ref type="bibr" target="#b36">[36]</ref><ref type="bibr" target="#b37">[37]</ref><ref type="bibr" target="#b38">[38]</ref> met all predefined inclusion criteria and therefore were included in the meta-analysis (Fig <ref type="figure">1</ref>).</s><s>The representative search strategies are illustrated in S1 File.</s><s>The total number of patients included was 1258.</s><s>The main characteristics of the eligible studies are summarized in Table <ref type="table" target="#tab_0">1</ref>.</s><s>Ten articles provided clinicopathological features, seven studies included data on OS and four studies included data on DFS.</s><s>The median follow-up of 7 studies is illustrated in Table <ref type="table" target="#tab_0">1</ref>.</s><s>The patient population of most studies was rather heterogeneous with patients of all clinical stages.</s><s>Twelve studies did not include patients with distant metastases.</s><s>The percentage of patients with distant metastases in the residual studies was 50% to 87.9% <ref type="bibr" target="#b16">[16,</ref><ref type="bibr" target="#b30">30]</ref>.</s><s>HPV status was detected in four studies.</s><s>Subsites of primary tumors of twelve studies are illustrated in S1 Table including 413 oral cancers, 509 OPSCC and 177 at other sites.</s><s>Information on treatment modalities was provided in only a single study.</s><s>Therefore, treatment was not included in our statistical analysis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Correlation of ALDH1 expression with clinicopathological parameters</head><p><s>All studies used immunohistochemistry (IHC) with cut-off values between any staining to &gt;10% positivity.</s><s>Isoenzymes of ALDH1 are e.g., ALDH1A1, ALDH1A2, and ALDH1A3.</s><s>The antibodies used, when described, were specific for all isoforms of ALDH1 in four studies, and ALDH1A1 in ten studies.</s><s>Therefore, we used the term "ALDH1" in our analysis.</s><s>The association of ALDH1 expression with clinicopathological parameters is illustrated in ALDH1 expression and disease-free survival DFS was investigated in 4 studies including 368 patients <ref type="bibr" target="#b17">[17,</ref><ref type="bibr" target="#b31">[31]</ref><ref type="bibr" target="#b32">[32]</ref><ref type="bibr" target="#b33">[33]</ref>.</s><s>We performed a metaanalysis on the DFS of ALDH + and ALDHpatients.</s><s>There was no significant association between ALDH1 expression and DFS (RR = 1.05; 95% CI: 0.35-3.16;</s><s>P = 0.94, random effect; Fig <ref type="figure" target="#fig_3">3A</ref>), again with significant heterogeneity (P&lt;0.0001;</s><s>I 2 = 88%).</s><s>Then, we performed a sensitivity analysis where omission of each single article's data did not result in obvious change in heterogeneity.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ALDH1 expression and 5-year overall survival outcome</head><p><s>We analyzed the OS of 672 patients from seven articles <ref type="bibr" target="#b5">[5,</ref><ref type="bibr" target="#b17">17,</ref><ref type="bibr" target="#b29">29,</ref><ref type="bibr" target="#b30">30,</ref><ref type="bibr" target="#b33">33,</ref><ref type="bibr" target="#b36">36,</ref><ref type="bibr" target="#b37">37]</ref>.</s><s>Using the DerSimonian-Laird fixed effects model, the meta-analysis on the OS of ALDH + and ALDHpatients did not reach a statistical significance (RR = 1.44; 95% CI: 0.93-2.23,</s><s>P = 0.10, random effect; Fig <ref type="figure" target="#fig_3">3B</ref>).</s><s>The forest plot showed a high level of heterogeneity, which was significant (I- squared and Q-test, P = 0.0002; I 2 = 77%).</s><s>In order to show the individual influence of each study on the over-all heterogeneity, we performed a sensitivity analysis by which each study was removed from the pool of studies once and I 2 and Q value was calculated.</s><s>We demonstrated that the study of Zhang et al. <ref type="bibr" target="#b36">[36]</ref> was the source of heterogeneity (S2 Fig)</s></p><note type="other">.</note></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Risk of bias of included studies and publication bias</head><p><s>Regarding to the NOS scale, all included studies had a score greater than 5 indicating a high quality of each study (S2 Table <ref type="table">)</ref>.</s><s>Begg's funnel and Egger's test were used to access the publication bias for each item (Table <ref type="table" target="#tab_1">2</ref>).</s><s>Egger's test showed no significant publication bias for Tstage (t = 0.70, P = 0.508), lymph node status (t = 1.01,</s><s>P = 0.352), differentiation grade (t = 1.17,</s><s>P = 0.306), OS (t = 0.83, P = 0.442) and DFS (t = -0.30,</s><s>P = 0.792).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>ALDH1-expression is a commonly used marker identifying putative CSC in a variety of epithelial tumors directly or indirectly, to identify cells displaying resistance to conventional cancer treatments <ref type="bibr" target="#b13">[13]</ref>.</s><s>In this meta-analysis, the presence of ALDH1-positive cells in HNSCC was analyzed regarding tumor grading, stage at first diagnosis, and clinical outcomes.</s><s>We showed that the presence of ALDH1-positive cells within primary tumors was strongly associated with a higher grading, which means with more dedifferentiated tumors.</s><s>It is hypothesized that putative stem cells are not a defined subpopulation within the malignant cells.</s><s>The development from CSC to more differentiated cancer cells at the same tumor site or after dissemination is believed to be continuous.</s><s>Specific embryonic stem cell-associated transcriptional regulators and gene expression pathways appear to be more upregulated in poorly differentiated but not in well differentiated tumors <ref type="bibr" target="#b40">[40]</ref>.</s><s>On a cellular level, some of these transcriptional factors associated with embryonic stem cells, e. g., Sox2, Oct3/4, and  Nanog were significantly upregulated in ALDH1-postive CSC <ref type="bibr" target="#b41">[41]</ref>.</s><s>Accordingly, low-grade tumors should contain mostly differentiated cells and few CSC, and high-grade tumors should contain highly dedifferentiated cells exhibiting stem cell-like features and a high percentage of CSC, a notion which we proved to be true in our meta-analysis.</s><s>Recently, the dedifferentiation from non-CSC into ZsGreen-cODC-positive CSC, a subpopulation of ALDH1-positive cells, was found in both HPV-negative and HPV-positive HNSCC cell lines in response to radiation <ref type="bibr" target="#b42">[42]</ref>.</s><s>Moreover, HPV-positive HNSCC cells that survived radiation dedifferentiated in CSC at lower rates while HPV-negative HNSCC had a higher rate.</s><s>This phenomenon not only demonstrates that dedifferentiation exists during radiotherapy and thus the capacity of CSC for repopulation, but also explains in part the better survival for patients with HPV-positive HNSCC.</s><s>However, very little is known of whether a dedifferentiation from non-CSC to CSC on a cellular level is possible.</s><s>What is known is that epithelial-mesenchymal transition (EMT) and its reversed process mesenchymal-epithelial transition is related to the acquisition of stem cell properties.</s><s>It appears that EMT can reprogram differentiated mammary epithelial cells into less differentiated epithelial stem cells with mesenchymal traits <ref type="bibr" target="#b43">[43]</ref>.</s><s>It also has been demonstrated in HNSCC that overexpression of ALDH1 dramatically decreased expression of epithelial markers but increased expression of mesenchymal markers <ref type="bibr" target="#b3">[4]</ref> leading to enhanced invasiveness and metastatic potential <ref type="bibr" target="#b44">[44]</ref>.</s><s>A better understanding of how and why CSC are induced and modulated local-regionally might suggest ways to target them.</s><s>HNSCC is used to describe all carcinomas arising from the stratified squamous epithelium lining the sinonasal tract, oral cavity, oropharynx, pharynx, and larynx.</s><s>Histologically, squamous cell carcinoma is characterized by microscopic evidence of squamous differentiation and invasive growth.</s><s>In most cases, the histological grading of these tumors is directly linked to the clinical stage at first diagnosis.</s><s>At least for oral HNSCC, poorly differentiated tumors are more likely correlated with a positive nodal status, extracapsular spread, and perineural invasion <ref type="bibr" target="#b45">[45]</ref>.</s><s>Given the fact, that we found a clear association of ALDH1-expression with high histological grade, we expected an association of ALDH1 expression with clinical stage, T-and Nstatus.</s><s>In a previous meta-analysis, Zhou et al. showed that the ALDH1 expression was significantly associated with lymph node metastasis, but not T-stage and the presence of distant metastases <ref type="bibr" target="#b46">[46]</ref>.</s><s>However, our analysis did not show significant impact of ALDH1 expression on disease stage.</s><s>The discrepancy of the results may be due to the recent publications <ref type="bibr" target="#b33">[33,</ref><ref type="bibr" target="#b35">35,</ref><ref type="bibr" target="#b36">36]</ref> enrolled in the dataset which have shown no significant correlations between lymph node metastasis and CSC.</s><s>Although a significant correlation of ALDH1 CSC with nodal status was not concluded in this meta-analysis, in patterns of primary tumor and its corresponding nodal metastases, we <ref type="bibr">(Qian et al.)</ref> showed that the proportion of ALDH1-expressing cells was significantly increased in nodal metastases compared to their corresponding primary tumors <ref type="bibr" target="#b16">[16]</ref>.</s><s>We also observed in vitro as a property of CSC an increased invasive capacity and expression of EMT-markers and decreased expression of adhesion molecule E-cadherin <ref type="bibr" target="#b3">[4]</ref>.</s><s>In addition, the EMT process can be reversed by transfer of miR34a-mimics into HNSCC cells <ref type="bibr" target="#b41">[41]</ref>.</s><s>We are currently planning a morphoproteomics-based prospective study to further investigate the outcome of HNSCC regarding CSC and EMT markers in order to tailor the possibility of biomarker-directed therapy.</s></p><p><s>In addition, HPV status may also be responsible for discrepant results.</s><s>There was no correlation between ALDH1 expression and nodal metastases when only HPVtumors were included in the study of Leinung et al. <ref type="bibr" target="#b37">[37]</ref>.</s><s>The study by Zhang et al. <ref type="bibr" target="#b36">[36]</ref> showed that HPV16 + OPSCC had a higher intrinsic CSC pool than HPV -OPSCC and no correlation was found between nodal status and ALDH1 positive CSC for the whole cohort.</s><s>Because the authors did not perform the subgroup analysis based on HPV status, the frequency of CSC in HPV + and HPVtumors was not documented.</s><s>According to the recent report of global incidence of HPV infection in head and neck cancer <ref type="bibr" target="#b47">[47]</ref>, around 30% of OPSCC are caused by HPV, followed by oral cavity and larynx.</s><s>The majority of subsites included in this metaanalysis are OPSCC, oral cavity and larynx.</s><s>Thus, discrimination on HPV status to assess the effect of ALDH1 expression on lymph node metastasis is helpful to confirm or rebut this hypothesis.</s></p><p><s>The weakness of our meta-analysis is mainly the heterogeneity of studies and lack of clinical data.</s><s>We could not find a statistical difference in DFS, which is a discrepancy compared to a previously published evaluation <ref type="bibr" target="#b46">[46]</ref>.</s><s>Indeed, several factors may account for the discrepancy of survival between two datasets.</s><s>While the study by Liu et al. showed a clear signal for ALDH1 being associated with a shorter PFS, Martin et al. found the opposite result.</s><s>Here it is important to note that the study by Liu et al.</s><s>only included carcinomas of oral cavity <ref type="bibr" target="#b32">[32]</ref>.</s><s>Martin et al., on the other hand, included only laryngeal carcinomas with a portion of 26% stage IV patients <ref type="bibr" target="#b33">[33]</ref>.</s><s>Anatomic site, stage and histological characteristics are considered to be of importance for risk stratification of HNSCC <ref type="bibr" target="#b48">[48]</ref><ref type="bibr" target="#b49">[49]</ref><ref type="bibr" target="#b50">[50]</ref>.</s><s>As shown in a recent report by The Cancer Genome Atlas Network <ref type="bibr" target="#b51">[51]</ref>, increased expression of oxidative stress response genes associated with chemoresistance was found in laryngeal carcinomas while oral cavity tumors exhibit lower expression of genes related to DNA repair.</s><s>Other confounding factors may include different ALDH1 testing methods used in each study and different treatment protocols.</s><s>The prognostic impact of ALDH1 positivity on OS in HNSCC patients has been detected in seven of fourteen studies.</s><s>When one source study was excluded, there was a significant impact of ALDH1 positivity on OS.</s><s>Again, the observed heterogeneity of the patient populations is more likely to be responsible for the equivocal findings.</s><s>The study by Zhang et al. <ref type="bibr" target="#b36">[36]</ref> included exclusively HPV + LA tumors which was associated with a favorable outcome than HPV -LA tumors <ref type="bibr" target="#b52">[52]</ref>.</s><s>Also, differences do exist in the CSC pool of HPV + tumors and HPVtumors <ref type="bibr" target="#b16">[16,</ref><ref type="bibr" target="#b42">42]</ref>.</s><s>There are disagreements between the study of Zhang et al.</s><s>where HPV + HNSCC cells had a greater intrinsic CSC pool and other studies which showed a significantly lower frequency of CSCs in HPV + tumors <ref type="bibr" target="#b42">[42,</ref><ref type="bibr" target="#b53">53]</ref>.</s><s>In addition, because the patient samples enrolled in the Zhang study were microarrays, there would be limitations to conclude the results based on the selected tumor cores.</s><s>They observed ALDH1 staining in &gt;50% of the tumor cells in selected HPVand HPV16 + OPSCC tumor cores.</s><s>However, in our own study, the ALDH1 staining ranged from 0 to &gt;50% in primary tumor and its corresponding nodal metastases.</s><s>We also found higher ALDH1 expression grades and negative HPV status for primary tumors but not for metastases.</s><s>These findings are consistent with studies in HNSCC cell lines which have shown HPV + cell lines had lower numbers of CSCs <ref type="bibr" target="#b41">[41]</ref> and inversely correlated with radiosensitivity <ref type="bibr" target="#b42">[42]</ref>.</s><s>Although these studies seem contradictory, it is worth noting that a small proportion of less radioresistant CSCs being identified in HPV-induced HNSCC were positively associated with decreased local regional control <ref type="bibr" target="#b54">[54]</ref> indicating a contribution of CSC to the decreased local regional control in HPV + tumors.</s><s>The reason behind the observed differences warrants further investigations.</s></p><p><s>It is clear that CSC play crucial roles in tumorigenesis based on earlier observations, but currently its clinical relevance such as its proportions in pre-and post-treatment stage, response to treatment modalities and outcomes is still limited.</s><s>The data revealed that ALDH1 expression is associated with tumor histology independent of HPV status indicating ALDH1positive CSC as a potentially valuable tool in clinical management of HNSCC.</s><s>The data also revealed the potentially prognostic value of ALDH1-positive CSC in HNSCC.</s><s>It is necessary to further investigate the value of CSC presence as markers in stratified HNSCC subgroups based on factors such as HPV-association or tumor site.</s><s>Treatment modalities targeting CSC populations in order to improve therapy are also currently of interest.</s><s>Kulsum et al. demonstrated that ALDH1A1 inhibition improved the effectiveness of cisplatin treatment, reduced the migration rate, self-renewal capacity and tumorigenicity of cancer cells in vitro.</s><s>Further, an ex</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>Fig 1. Flow-chart for identification of eligible studies.</s><s>https://doi.org/10.1371/journal.pone.0187615.g001</s></p></div></figDesc><graphic coords="4,200.01,434.61,299.91,248.54" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>The removal of the latter study from the pooled population resulted in a significantly reduced I 2 value.</s><s>Analysis of the modified patient population showed a conspicuous shorter OS in patients with positive ALDH1 expression (RR = 1.77, 95% CI: 1.41-2.22,</s><s>P&lt;0.0001, random effect), which was illustrated in the modified forest plot (Fig3C).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig 2 .</head><label>2</label><figDesc><div><p><s>Fig 2. Forest plot describing the association between ALDH1 expression and odds ration (OR) for clinical pathological features.</s><s>Forest plot of OR for the (A) differentiation grading, (B) clinical staging, (C) lymph node status, (D) tumor T stage of the ALDH1 + group compared to ALDH1group.</s><s>https://doi.org/10.1371/journal.pone.0187615.g002</s></p></div></figDesc><graphic coords="6,200.01,72.00,299.91,319.12" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig 3 .</head><label>3</label><figDesc><div><p><s>Fig 3. Meta-analysis for adjusted relative risk (RR) of the disease-free survival (DFS) or overall survival (OS) compared to the ALDH1 + subgroup.</s><s>Forest plot of RR among included studies for the DFS of the ALDH1 + group compared to ALDH1group (A).</s><s>Forest plot of RR for the OS (B) and adjusted OS (C) of the ALDH1 + group compared to ALDH1group.</s><s>https://doi.org/10.1371/journal.pone.0187615.g003</s></p></div></figDesc><graphic coords="7,200.01,78.01,359.94,294.86" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 . Main characteristics and results of the eligible studies. Author Year Country Number of Patients Site Tumor Stage (UICC) Antibody Cut-off score (H/L) HPV status Median follow-up</head><label>1</label><figDesc></figDesc><table><row><cell>Chen YW [29]</cell><cell>2010 Taiwan</cell><cell>111</cell><cell cols="2">HNSCC ND</cell><cell>ND, Abcam</cell><cell>ND</cell><cell>ND</cell><cell>75 months</cell></row><row><cell>Koukourakis MI</cell><cell>2012 Greece</cell><cell>74</cell><cell cols="2">HNSCC I-III</cell><cell>Rabbit mAb, EP1933Y,</cell><cell>5%</cell><cell>ND</cell><cell>24 months (4-80</cell></row><row><cell>[31]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Abcam</cell><cell></cell><cell></cell><cell>months)</cell></row><row><cell>Michifuri Y [34]</cell><cell>2012 Japan</cell><cell>80</cell><cell cols="2">OSCC I-III</cell><cell>Mouse mAb, clone 44, BD</cell><cell>2%</cell><cell>ND</cell><cell>ND</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Pharmingen</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Xu J [17]</cell><cell>2012 USA</cell><cell>96</cell><cell cols="2">HNSCC I-IV</cell><cell>N-19, Santa Cruz</cell><cell>0</cell><cell>ND</cell><cell>62 months (12-</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>150 months)</cell></row><row><cell>Liu W [32]</cell><cell>2013 China</cell><cell>141</cell><cell cols="2">OSCC ND</cell><cell>Rabbit mAb, ab52492,</cell><cell>5%</cell><cell>ND</cell><cell>66 months</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Abcam</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Chen C [39]</cell><cell>2013 China</cell><cell>60</cell><cell cols="2">HNSCC ND</cell><cell>ND, BD Biosciences</cell><cell>ND</cell><cell>ND</cell><cell>ND</cell></row><row><cell>Qian X [16]</cell><cell cols="2">2013 Germany 80</cell><cell cols="2">OPSCC I-IV</cell><cell>Mouse mAb, clone 44; BD</cell><cell>5%</cell><cell>Yes</cell><cell>ND</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Biosciences</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Ota N [35]</cell><cell>2014 Japan</cell><cell>90</cell><cell cols="2">OSCC I-IV</cell><cell>Mouse mAb, clone 44; BD</cell><cell>5%</cell><cell>ND</cell><cell>ND</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Biosciences</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Zhang M [36]</cell><cell>2014 USA</cell><cell>222</cell><cell cols="2">OPSCC ND</cell><cell>Mouse mAb, clone 44; BD</cell><cell>ND</cell><cell>Yes</cell><cell>ND</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Biosciences</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Huang CF [30]</cell><cell>2014 China</cell><cell>66</cell><cell>TSCC</cell><cell>I-IV</cell><cell>Polyclonal rabbit Ab,</cell><cell>10%</cell><cell>ND</cell><cell>52 months (2-104</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Proteintech Group Inc.</cell><cell></cell><cell></cell><cell>months)</cell></row><row><cell>Qian X [5]</cell><cell cols="2">2014 Germany 81</cell><cell cols="2">HNSCC I-III</cell><cell>Mouse mAb, clone 44; BD</cell><cell>5%</cell><cell>Yes</cell><cell>ND</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Biosciences</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Leinung M [37]</cell><cell cols="2">2015 Germany 48</cell><cell cols="2">HNSCC ND</cell><cell>Rabbit mAb, ab52492;</cell><cell>ND</cell><cell>Yes</cell><cell>120 months</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Abcam</cell><cell></cell><cell></cell><cell></cell></row><row><cell>Martı ´n M [33]</cell><cell>2016 Spain</cell><cell>57</cell><cell>LSCC</cell><cell>I-IV</cell><cell>ND, Abcam</cell><cell>ND</cell><cell>ND</cell><cell>42 months</cell></row><row><cell>de Moraes FP</cell><cell>2016 Brazil</cell><cell>52</cell><cell cols="2">HNSCC I-IV</cell><cell>EP1933Y, Abcam</cell><cell>10%</cell><cell>ND</cell><cell>ND</cell></row><row><cell>[38]</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>IHC: immunohistochemistry; HNSCC: head and neck squamous cell carcinoma; OSCC: oral squamous cell carcinomas; TSCC: tongue squamous cell carcinoma; LSCC: laryngeal squamous cell carcinoma; OSCC: oral squamous cell cancer; OPSCC: oropharyngeal squamous cell carcinomas; ND: not documented.https://doi.org/10.1371/journal.pone.0187615.t001</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 . Egger's test of funnel plot asymmetry.</head><label>2</label><figDesc></figDesc><table><row><cell>Clinicopathological parameters</cell><cell>t value</cell><cell>df</cell><cell>p value</cell></row><row><cell>Tumor grade</cell><cell>1.17</cell><cell>5</cell><cell>0.306</cell></row><row><cell>Lymph node metastasis</cell><cell>1.01</cell><cell>7</cell><cell>0.352</cell></row><row><cell>Tumor T stage</cell><cell>0.70</cell><cell>7</cell><cell>0.508</cell></row><row><cell>Overall survival</cell><cell>0.83</cell><cell>6</cell><cell>0.442</cell></row><row><cell>Disease free survival</cell><cell>-0.30</cell><cell>3</cell><cell>0.792</cell></row><row><cell>df: degrees of freedom.</cell><cell></cell><cell></cell><cell></cell></row></table><note><p><s>https://doi.org/10.1371/journal.pone.0187615.t002</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">PLOS ONE | https://doi.org/10.1371/journal.pone.0187615November 7, 2017  </note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>vivo study continuously showed that ALDH1A1-specific inhibitor in combination with cisplatin significantly decreased the proliferation of cells as compared to individual treatment <ref type="bibr" target="#b18">[18]</ref>.</s><s>Thus, strategies to introduce ALDH1A1-specific inhibitors to current chemoradiotherapy regimens, in an effort to target CSC and treatment-induced reprogramming, may become an ideal treatment to achieve better curative effects.</s></p><p><s>In conclusion, we have presented that ALDH1 expression is associated with tumor histology and has potential prognostic value independent of etiologies such as chronic alcohol, tobacco abuse, and HPV status in the meta-analysis.</s><s>Additional limitations of our meta-analysis are the number of included articles and that the sample size of each study was rather small.</s><s>There was heterogeneity of data among outcomes.</s><s>We acknowledge that because of the limited data for our question of interest such as HPV status and tumor subsites were not discriminated, the strength of our conclusion is limited.</s><s>Given the massive biases built in to case-control studies, ALDH1 as a putative biomarker should (at most) be presented as speculative.</s><s>Future large-scale prospective studies to establish and validate the prognostic value of ALDH1 are necessary.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Supporting information</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>S1</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Biology and immunology of cancer stem (-like) cells in head and neck cancer</title>
		<author>
			<persName><forename type="first">X</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Nie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lenarz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.critrevonc.2015.03.009</idno>
		<idno type="PMID">25907739</idno>
		<ptr target="https://doi.org/10.1016/j.critrevonc.2015.03.009" />
	</analytic>
	<monogr>
		<title level="j">Critical reviews in oncology/hematology</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="337" to="345" />
			<date type="published" when="2015-04-25">2015. 2015/04/25</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Dick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">B</forename><surname>Dirks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Eaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Jamieson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Jones</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-06-3126</idno>
		<idno type="PMID">16990346</idno>
		<ptr target="https://doi.org/10.1158/0008-5472.CAN-06-3126" />
	</analytic>
	<monogr>
		<title level="j">Cancer research</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="9339" to="9344" />
			<date type="published" when="2006-09-23">2006. 2006/09/23</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proceedings of the National Academy of Sciences of the United States of America</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Prince</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Sivanandan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kaczorowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Wolf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Dalerba</surname></persName>
		</author>
		<idno type="DOI">10.1073/pnas.0610117104</idno>
		<idno type="PMID">17210912</idno>
		<ptr target="https://doi.org/10.1073/pnas.0610117104" />
		<imprint>
			<date type="published" when="2007-01-11">2007. 2007/01/11</date>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="973" to="978" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<title/>
		<idno type="DOI">10.1371/journal.pone.0016466</idno>
		<idno type="PMID">21304586</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0016466" />
		<imprint>
			<date type="published" when="2011-02-10">2011/02/10</date>
			<biblScope unit="volume">6</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Prognostic significance of ALDH1A1-positive cancer stem cells in patients with locally advanced, metastasized head and neck squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">X</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Coordes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gekeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Klussmann</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00432-014-1685-4</idno>
		<idno type="PMID">24770634</idno>
		<ptr target="https://doi.org/10.1007/s00432-014-1685-4" />
	</analytic>
	<monogr>
		<title level="j">Journal of cancer research and clinical oncology</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="1151" to="1158" />
			<date type="published" when="2014-04-29">2014. 2014/04/29</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<monogr>
		<title level="m" type="main">Unresectable primary tumor of head and neck: does neck dissection combined with chemoradiotherapy improve survival? The Journal of craniofacial surgery</title>
		<author>
			<persName><forename type="first">F</forename><surname>Carinci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cassano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pelucchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Calearo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Modugno</surname></persName>
		</author>
		<idno type="PMID">11572248</idno>
		<imprint>
			<date type="published" when="2001-09-27">2001. 2001/09/27</date>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="438" to="443" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main">PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. The New England journal of medicine</title>
		<author>
			<persName><forename type="first">H</forename><surname>Mehanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Mcconkey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Rahman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Hartley</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa1514493</idno>
		<idno type="PMID">27007578</idno>
		<ptr target="https://doi.org/10.1056/NEJMoa1514493" />
		<imprint>
			<date type="published" when="2016-03-24">2016. 2016/03/24</date>
			<biblScope unit="volume">374</biblScope>
			<biblScope unit="page" from="1444" to="1454" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Taxane-cisplatin-fluorouracil as induction chemotherapy for advanced head and neck cancer: a meta-analysis of the 5-year efficacy and safety</title>
		<author>
			<persName><forename type="first">X</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">K</forename><surname>Hoffmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Albers</surname></persName>
		</author>
		<idno type="DOI">10.1186/s40064-015-0988-5</idno>
		<idno type="PMID">25977896</idno>
		<ptr target="https://doi.org/10.1186/s40064-015-0988-5" />
	</analytic>
	<monogr>
		<title level="j">SpringerPlus</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">208</biblScope>
			<date type="published" when="2015-05-16">2015. 2015/05/16</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Efficacy and toxicity of docetaxel combination chemotherapy for advanced squamous cell cancer of the head and neck</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Albers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Grabow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Jumah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">M</forename><surname>Hofmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Krannich</surname></persName>
		</author>
		<idno type="DOI">10.3892/mco.2017.1281</idno>
		<idno type="PMID">28685095</idno>
		<ptr target="https://doi.org/10.3892/mco.2017.1281" />
	</analytic>
	<monogr>
		<title level="j">Mol Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="151" to="157" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The molecular biology of head and neck cancer</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Leemans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Braakhuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Brakenhoff</surname></persName>
		</author>
		<idno type="DOI">10.1038/nrc2982</idno>
		<idno type="PMID">21160525</idno>
		<ptr target="https://doi.org/10.1038/nrc2982" />
	</analytic>
	<monogr>
		<title level="j">Nature reviews Cancer</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="9" to="22" />
			<date type="published" when="2010">2011. 2010/12/17</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<monogr>
		<title level="m" type="main">Can &quot;early&quot; and &quot;late&quot;18F-FDG PET-CT be used as prognostic factors for the clinical outcome of patients with locally advanced head and neck cancer treated with radio-chemotherapy? Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology</title>
		<author>
			<persName><forename type="first">P</forename><surname>Castaldi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Rufini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bussu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Micciche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dinapoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Autorino</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.radonc.2012.03.001</idno>
		<idno type="PMID">22459579</idno>
		<ptr target="https://doi.org/10.1016/j.radonc.2012.03.001" />
		<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="63" to="68" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title level="m" type="main">Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA: a cancer journal for clinicians</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Lydiatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>O'sullivan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Brandwein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Ridge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Migliacci</surname></persName>
		</author>
		<idno type="DOI">10.3322/caac.21389</idno>
		<idno type="PMID">28128848</idno>
		<ptr target="https://doi.org/10.3322/caac.21389" />
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="122" to="137" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform</title>
		<author>
			<persName><forename type="first">P</forename><surname>Marcato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Dean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Giacomantonio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">W</forename><surname>Lee</surname></persName>
		</author>
		<idno type="DOI">10.4161/cc.10.9.15486</idno>
		<idno type="PMID">21552008</idno>
		<ptr target="https://doi.org/10.4161/cc.10.9" />
	</analytic>
	<monogr>
		<title level="j">Cell cycle</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1378" to="1384" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Retinal oxidation activity and biological role of human cytosolic aldehyde dehydrogenase</title>
		<author>
			<persName><forename type="first">A</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Dave</forename><forename type="middle">V</forename></persName>
		</author>
		<idno type="PMID">1292933</idno>
	</analytic>
	<monogr>
		<title level="j">Enzyme</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">4-5</biblScope>
			<biblScope unit="page" from="239" to="244" />
			<date type="published" when="1992-01-01">1992. 1992/01/01</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Hsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">K</forename><surname>Tai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Tseng</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.oraloncology.2009.11.007</idno>
		<idno type="PMID">20036608</idno>
		<ptr target="https://doi.org/10.1016/j.oraloncology.2009.11.007" />
	</analytic>
	<monogr>
		<title level="j">Oral oncology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="158" to="165" />
			<date type="published" when="2009">2010. 2009/12/29</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">ALDH1-positive cancer stem-like cells are enriched in nodal metastases of oropharyngeal squamous cell carcinoma independent of HPV status</title>
		<author>
			<persName><forename type="first">X</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Klussmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
		</author>
		<idno type="DOI">10.3892/or.2013.2340</idno>
		<idno type="PMID">23483187</idno>
		<ptr target="https://doi.org/10.3892/or.2013.2340" />
	</analytic>
	<monogr>
		<title level="j">Oncology reports</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1777" to="1784" />
			<date type="published" when="2013-03-14">2013. 2013/03/14</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Comparison of quantum dot technology with conventional immunohistochemistry in examining aldehyde dehydrogenase 1A1 as a potential biomarker for lymph node metastasis of head and neck cancer</title>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nannapaneni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Peng</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejca.2011.12.029</idno>
		<idno type="PMID">22341992</idno>
		<ptr target="https://doi.org/10.1016/j.ejca.2011.12.029" />
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1682" to="1691" />
			<date type="published" when="2012-02-22">2012. 2012/02/22</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<monogr>
		<title level="m" type="main">Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition. Molecular carcinogenesis</title>
		<author>
			<persName><forename type="first">S</forename><surname>Kulsum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">V</forename><surname>Sudheendra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Pandian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Ravindra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Siddappa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R N</forename></persName>
		</author>
		<idno type="DOI">10.1002/mc.22526</idno>
		<idno type="PMID">27380877</idno>
		<ptr target="https://doi.org/10.1002/mc.22526" />
		<imprint>
			<date type="published" when="2016-07-07">2017. 2016/07/07</date>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="694" to="711" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<monogr>
		<title level="m" type="main">Identification of human aldehyde dehydrogenase 1 family member A1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck. Cancer research</title>
		<author>
			<persName><forename type="first">C</forename><surname>Visus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Amoscato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maciejewska-Franczak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Abdelsalem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dhir</surname></persName>
		</author>
		<idno type="DOI">10.1158/0008-5472.CAN-07-1346</idno>
		<idno type="PMID">17974998</idno>
		<ptr target="https://doi.org/10.1158/0008-5472.CAN-07-1346" />
		<imprint>
			<date type="published" when="2007">2007. 2007/ 11/03</date>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="10538" to="10545" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<monogr>
		<title level="m" type="main">Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8(+) T cells. Clinical cancer research: an official journal of the</title>
		<author>
			<persName><forename type="first">C</forename><surname>Visus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lozano-Leon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Ferris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Silver</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Szczepanski</surname></persName>
		</author>
		<idno type="DOI">10.1158/1078-0432.ccr-11-1111</idno>
		<idno type="PMID">21856769</idno>
		<ptr target="https://doi.org/10.1158/1078-0432.ccr-11-1111" />
		<imprint>
			<date type="published" when="2011">2011. 2011</date>
			<publisher>American Association for Cancer Research</publisher>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="6174" to="6184" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<monogr>
		<title level="m" type="main">The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Wells</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Sb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>'connell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Peterson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Welch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Losos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Tugwell</surname></persName>
		</author>
		<ptr target="http://wwwohrica/programs/clinical_epidemiology/oxfordasp.2014" />
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis</title>
		<author>
			<persName><forename type="first">F</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Ning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0163678</idno>
		<idno type="PMID">27684938</idno>
		<ptr target="https://doi.org/10.1371/journal.pone.0163678" />
	</analytic>
	<monogr>
		<title level="j">PloS one</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page">e0163678</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<monogr>
		<title level="m" type="main">Cochrane Handbook version 5.1.0. The Cochrane Collaboration</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Green</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Parmar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Torri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Stewart</surname></persName>
		</author>
		<idno type="PMID">9921604</idno>
	</analytic>
	<monogr>
		<title level="j">Statistics in medicine</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">24</biblScope>
			<biblScope unit="page" from="2815" to="2834" />
			<date type="published" when="1998">1998. 1999/01/28</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Measuring inconsistency in meta-analyses</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Deeks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Altman</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.327.7414.557</idno>
		<idno type="PMID">12958120</idno>
		<ptr target="https://doi.org/10.1136/bmj.327.7414.557" />
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">327</biblScope>
			<biblScope unit="issue">7414</biblScope>
			<biblScope unit="page" from="557" to="560" />
			<date type="published" when="2003-09-06">2003. 2003/09/06</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Meta-analysis in clinical trials</title>
		<author>
			<persName><forename type="first">R</forename><surname>Dersimonian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Laird</surname></persName>
		</author>
		<idno type="PMID">3802833</idno>
	</analytic>
	<monogr>
		<title level="j">Controlled clinical trials</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="177" to="188" />
			<date type="published" when="1986-09-01">1986. 1986/09/01</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Bias in meta-analysis detected by a simple, graphical test</title>
		<author>
			<persName><forename type="first">M</forename><surname>Egger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Davey</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schneider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Minder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<idno type="PMID">9310563</idno>
	</analytic>
	<monogr>
		<title level="j">Clinical research ed)</title>
		<imprint>
			<biblScope unit="volume">315</biblScope>
			<biblScope unit="issue">7109</biblScope>
			<biblScope unit="page" from="629" to="634" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>BMJ</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Expression of ALDH1 and a-SMA in head and neck squamous cell carcinoma and its clinicopathological significance</title>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Zhejiang Med J</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="867" to="870" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma-derived CD44(+)ALDH1(+) cells</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">I</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">Y</forename><surname>Chiou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">L</forename><surname>Lo</surname></persName>
		</author>
		<idno type="DOI">10.1158/1535-7163.MCT-10-0504</idno>
		<idno type="PMID">21062915</idno>
		<ptr target="https://doi.org/10.1158/1535-7163.MCT-10-0504" />
	</analytic>
	<monogr>
		<title level="j">Mol Cancer Ther</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2879" to="2892" />
			<date type="published" when="2010">2010. 2010/11/11</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">R</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">J</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">F</forename><surname>Zhang</surname></persName>
		</author>
		<idno type="DOI">10.1111/jop.12159</idno>
		<idno type="PMID">24450601</idno>
		<ptr target="https://doi.org/10.1111/jop.12159" />
	</analytic>
	<monogr>
		<title level="j">J Oral Pathol Med</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="492" to="498" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Cancer stem cell phenotype relates to radio-chemotherapy outcome in locally advanced squamous cell head-neck cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Koukourakis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Giatromanolaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Tsakmaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Danielidis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sivridis</surname></persName>
		</author>
		<idno type="DOI">10.1038/bjc.2012.33</idno>
		<idno type="PMID">22333601</idno>
		<ptr target="https://doi.org/10.1038/bjc.2012.33" />
	</analytic>
	<monogr>
		<title level="j">British journal of cancer</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="846" to="853" />
			<date type="published" when="2012-02-16">2012. 2012/02/16</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia</title>
		<author>
			<persName><forename type="first">W</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">M</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">Q</forename><surname>Xu</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.27720</idno>
		<idno type="PMID">22782852</idno>
		<ptr target="https://doi.org/10.1002/ijc.27720" />
	</analytic>
	<monogr>
		<title level="j">International journal of cancer Journal international du cancer</title>
		<imprint>
			<biblScope unit="volume">132</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="868" to="874" />
			<date type="published" when="2012-07-12">2013. 2012/07/12</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer</title>
		<author>
			<persName><forename type="first">M</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hinojar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cerezo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Garcia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Prada</surname></persName>
		</author>
		<idno type="DOI">10.1007/s12094-015-1445-1</idno>
		<idno type="PMID">26572760</idno>
		<ptr target="https://doi.org/10.1007/s12094-015-1445-1" />
	</analytic>
	<monogr>
		<title level="j">Clin Transl Oncol</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="825" to="830" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Michifuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hirohashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Torigoe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Miyazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kobayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Sasaki</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.1440-1827.2012.02851.x</idno>
		<idno type="PMID">23005595</idno>
		<ptr target="https://doi.org/10.1111/j.1440-1827.2012.02851.x" />
	</analytic>
	<monogr>
		<title level="j">Pathol Int</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="684" to="689" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">In vitro and in vivo expression of aldehyde dehydrogenase 1 in oral squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">N</forename><surname>Ota</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ohno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Seno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Taniguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ozeki</surname></persName>
		</author>
		<idno type="DOI">10.3892/ijo.2013.2188</idno>
		<idno type="PMID">24285422</idno>
		<ptr target="https://doi.org/10.3892/ijo.2013.2188" />
	</analytic>
	<monogr>
		<title level="j">International journal of oncology</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="435" to="442" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">M</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Piao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schmitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Arradaza</surname></persName>
		</author>
		<idno type="DOI">10.1002/cncr.28538</idno>
		<idno type="PMID">24382806</idno>
		<ptr target="https://doi.org/10.1002/cncr.28538" />
	</analytic>
	<monogr>
		<title level="j">Cancer</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="992" to="1001" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Expression of ALDH1A1 and CD44 in primary head and neck squamous cell carcinoma and their value for carcinogenesis, tumor progression and cancer stem cell identification</title>
		<author>
			<persName><forename type="first">M</forename><surname>Leinung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ernst</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Doring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wagenblast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tahtali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Diensthuber</surname></persName>
		</author>
		<idno type="DOI">10.3892/ol.2015.3542</idno>
		<idno type="PMID">26622836</idno>
		<ptr target="https://doi.org/10.3892/ol.2015.3542" />
	</analytic>
	<monogr>
		<title level="j">Oncol Lett</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="2289" to="2294" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<monogr>
		<title level="m" type="main">Expression of stem cell markers in oral cavity and oropharynx squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>De Moraes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">V</forename><surname>Lourenco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Ianez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>De Sousa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Damascena</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.oooo.2016.09.009</idno>
		<idno type="PMID">27866975</idno>
		<ptr target="https://doi.org/10.1016/j.oooo.2016.09.009" />
		<imprint>
			<date type="published" when="2017">2017</date>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="113" to="122" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<title level="m" type="main">Expression of ALDH1 and α-SMA in head and neck squamous cell carcinoma and its clinicopathological significance. Zhejiang Yixue</title>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ge</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="867" to="870" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors</title>
		<author>
			<persName><forename type="first">I</forename><surname>Ben-Porath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Thomson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">J</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Bell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Regev</surname></persName>
		</author>
		<idno type="DOI">10.1038/ng.127</idno>
		<idno type="PMID">18443585</idno>
		<ptr target="https://doi.org/10.1038/ng.127" />
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="499" to="507" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">MicroRNA-34a regulates epithelial-mesenchymal transition and cancer stem cell phenotype of head and neck squamous cell carcinoma in vitro</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Albers</surname></persName>
		</author>
		<idno type="DOI">10.3892/ijo.2015.3142</idno>
		<idno type="PMID">26323460</idno>
		<ptr target="https://doi.org/10.3892/ijo.2015.3142" />
	</analytic>
	<monogr>
		<title level="j">International journal of oncology</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1339" to="1350" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status</title>
		<author>
			<persName><forename type="first">E</forename><surname>Vlashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boyrie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Brower</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ijrobp.2016.01.005</idno>
		<idno type="PMID">27026319</idno>
		<ptr target="https://doi.org/10.1016/j.ijrobp.2016.01.005" />
	</analytic>
	<monogr>
		<title level="j">Int J Radiat Oncol Biol Phys</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1198" to="1206" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">The epithelial-mesenchymal transition generates cells with properties of stem cells</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Mani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Guo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">N</forename><surname>Eaton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ayyanan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">Y</forename><surname>Zhou</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.cell.2008.03.027</idno>
		<idno type="PMID">18485877</idno>
		<ptr target="https://doi.org/10.1016/j.cell.2008.03.027" />
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="704" to="715" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<monogr>
		<title level="m" type="main">Epithelial-to-mesenchymal transition and cancer stem(-like) cells in head and neck squamous cell carcinoma. Cancer letters</title>
		<author>
			<persName><forename type="first">C</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zimmermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Tinhofer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kaufmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Albers</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.canlet.2012.06.013</idno>
		<idno type="PMID">22771535</idno>
		<ptr target="https://doi.org/10.1016/j.canlet.2012.06.013" />
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">338</biblScope>
			<biblScope unit="page" from="47" to="56" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">Histological differentiation of primary oral squamous cell carcinomas in an area of betel quid chewing prevalence. Otolaryngol Head Neck Surg</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Fang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Kao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Tsang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.otohns.2009.09.012</idno>
		<idno type="PMID">19932848</idno>
		<ptr target="https://doi.org/10.1016/j.otohns.2009.09.012" />
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="page" from="743" to="749" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">The prognostic role of the cancer stem cell marker aldehyde dehydrogenase 1 in head and neck squamous cell carcinomas: a meta-analysis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sun</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.oraloncology.2014.08.018</idno>
		<idno type="PMID">25264224</idno>
		<ptr target="https://doi.org/10.1016/j.oraloncology.2014.08.018" />
	</analytic>
	<monogr>
		<title level="j">Oral oncology</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1144" to="1148" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Worldwide burden of cancer attributable to HPV by site, country and HPV type</title>
		<author>
			<persName><forename type="first">C</forename><surname>De Martel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Plummer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Vignat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Franceschi</surname></persName>
		</author>
		<idno type="DOI">10.1002/ijc.30716</idno>
		<idno type="PMID">28369882</idno>
		<ptr target="https://doi.org/10.1002/ijc.30716" />
	</analytic>
	<monogr>
		<title level="j">International journal of cancer Journal international du cancer</title>
		<imprint>
			<biblScope unit="volume">141</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="664" to="670" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Human papillomavirus and survival of patients with oropharyngeal cancer</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Ang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Wheeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Weber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Rosenthal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Nguyen-Tan</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMoa0912217</idno>
		<idno type="PMID">20530316</idno>
		<ptr target="https://doi.org/10.1056/NEJMoa0912217" />
	</analytic>
	<monogr>
		<title level="j">The New England journal of medicine</title>
		<imprint>
			<biblScope unit="volume">363</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="24" to="35" />
			<date type="published" when="2010-06-10">2010. 2010/06/10</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">The mutational landscape of head and neck squamous cell carcinoma</title>
		<author>
			<persName><forename type="first">N</forename><surname>Stransky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Egloff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Tward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Kostic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Cibulskis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sivachenko</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1208130</idno>
		<idno type="PMID">21798893</idno>
		<ptr target="https://doi.org/10.1126/science.1208130" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="issue">6046</biblScope>
			<biblScope unit="page" from="1157" to="1160" />
			<date type="published" when="2011-07-30">2011. 2011/07/ 30</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1</title>
		<author>
			<persName><forename type="first">N</forename><surname>Agrawal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Frederick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Pickering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bettegowda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Li</surname></persName>
		</author>
		<idno type="DOI">10.1126/science.1206923</idno>
		<idno type="PMID">21798897</idno>
		<ptr target="https://doi.org/10.1126/science.1206923" />
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">333</biblScope>
			<biblScope unit="issue">6046</biblScope>
			<biblScope unit="page" from="1154" to="1157" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Comprehensive genomic characterization of head and neck squamous cell carcinomas</title>
		<idno type="DOI">10.1038/nature14129</idno>
		<idno type="PMID">25631445</idno>
		<ptr target="https://doi.org/10.1038/nature14129" />
	</analytic>
	<monogr>
		<title level="j">Cancer Genome Atlas N</title>
		<imprint>
			<biblScope unit="volume">517</biblScope>
			<biblScope unit="issue">7536</biblScope>
			<biblScope unit="page" from="576" to="582" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>Nature</note>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title level="m" type="main">The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck. Annals of oncology: official journal of the European Society for Medical Oncology / ESMO</title>
		<author>
			<persName><forename type="first">A</forename><surname>Psyrri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rampias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Vermorken</surname></persName>
		</author>
		<idno type="DOI">10.1093/annonc/mdu265</idno>
		<idno type="PMID">25057165</idno>
		<ptr target="https://doi.org/10.1093/annonc/mdu265" />
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="2101" to="2115" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<monogr>
		<title level="m" type="main">HPV status, cancer stem cell marker expression, hypoxia gene signatures and tumour volume identify good prognosis subgroups in patients with HNSCC after primary radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG). Radiotherapy and oncology: journal of the European Society for Therapeutic Radiology and Oncology</title>
		<author>
			<persName><forename type="first">A</forename><surname>Linge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Lohaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Lock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nowak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gudziol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Valentini</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.radonc.2016.11.008</idno>
		<idno type="PMID">27913065</idno>
		<ptr target="https://doi.org/10.1016/j.radonc.2016.11.008" />
		<imprint>
			<date type="published" when="2016">2016</date>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="364" to="373" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Cancer stem cell enrichment marker CD98: a prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Rietbergen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Martens-De Kemp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bloemena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">I</forename><surname>Witte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Baatenburg De Jong</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejca.2013.11.010</idno>
		<idno type="PMID">24315751</idno>
		<ptr target="https://doi.org/10.1016/j.ejca.2013.11.010" />
	</analytic>
	<monogr>
		<title level="j">Eur J Cancer</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="765" to="773" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
